142 related articles for article (PubMed ID: 30479572)
1. Circulating natural antibodies to inflammatory cytokines are potential biomarkers for atherosclerosis.
Wang P; Zhao H; Wang Z; Zhang X
J Inflamm (Lond); 2018; 15():22. PubMed ID: 30479572
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance.
Cai W; Qiu C; Zhang H; Chen X; Zhang X; Meng Q; Wei J
J Inflamm (Lond); 2017; 14():24. PubMed ID: 29142506
[TBL] [Abstract][Full Text] [Related]
3. Further analysis of natural antibodies against ischemic stroke.
Qi J; Jiang Q; Wang P; Wang Z; Zhang X
Front Neurol; 2023; 14():1130748. PubMed ID: 36741286
[TBL] [Abstract][Full Text] [Related]
4. Analysis of plasma autoantibodies for inflammatory cytokines in patients with first-episode schizophrenia among a Chinese population.
Liu S; Zhang X; Wang J; Yang H; Jiang Y; Qiu C; Meng Q
J Neuroimmunol; 2020 Apr; 341():577165. PubMed ID: 32007786
[TBL] [Abstract][Full Text] [Related]
5. Amniotic fluid HIF1α and exosomal HIF1α in cervical insufficiency patients with physical examination-indicated cerclage.
Song JE; Park SJ; Lee KY; Lee WJ
J Matern Fetal Neonatal Med; 2019 Jul; 32(14):2287-2294. PubMed ID: 29357727
[TBL] [Abstract][Full Text] [Related]
6. Altered levels of circulating natural antibodies against VEGFR1-derived peptide in atherosclerosis.
Wang P; Liu S; Wang Z; Zhao H; Zhang X
J Int Med Res; 2020 Aug; 48(8):300060520948750. PubMed ID: 32811267
[TBL] [Abstract][Full Text] [Related]
7. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
8. Associations between circulating IgG antibodies to Apolipoprotein B
Hu W; Zhang X; Han Y; Wang Y; Lei M; Megson IL; Wei J; Jin Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30242056
[No Abstract] [Full Text] [Related]
9. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
10. Serum Immune Mediators Independently Associate with Atherosclerosis in the Left (But Not Right) Carotid Territory of Older Individuals.
Machado-Silva W; Henriques AD; Souza GD; Gomes L; Ferreira AP; Brito CJ; Córdova C; Moraes CF; Nóbrega OT
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2851-2858. PubMed ID: 27554076
[TBL] [Abstract][Full Text] [Related]
11. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
Wang J; Xu Y; Wang Y; Zhang X; Zhang G
Onco Targets Ther; 2019; 12():10487-10493. PubMed ID: 31819529
[TBL] [Abstract][Full Text] [Related]
12. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis.
Guimbaud R; Bertrand V; Chauvelot-Moachon L; Quartier G; Vidon N; Giroud JP; Couturier D; Chaussade S
Am J Gastroenterol; 1998 Dec; 93(12):2397-404. PubMed ID: 9860399
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
[TBL] [Abstract][Full Text] [Related]
14. Salivary inflammatory cytokines may be novel markers of carotid atherosclerosis in a Japanese general population: the Suita study.
Kosaka T; Kokubo Y; Ono T; Sekine S; Kida M; Kikui M; Yamamoto M; Watanabe M; Amano A; Maeda Y; Miyamoto Y
Atherosclerosis; 2014 Nov; 237(1):123-8. PubMed ID: 25238219
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome.
Willeke P; Schotte H; Schlüter B; Erren M; Becker H; Dyong A; Mickholz E; Domschke W; Gaubitz M
Ann Rheum Dis; 2003 Apr; 62(4):359-62. PubMed ID: 12634239
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
Liu S; Zhang X; Jiang Q; Liang T
FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
[TBL] [Abstract][Full Text] [Related]
19. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
[TBL] [Abstract][Full Text] [Related]
20. The Association of Circulating MiR-29b and Interleukin-6 with Subclinical Atherosclerosis.
Huang YQ; Li J; Chen JY; Zhou YL; Cai AP; Huang C; Feng YQ
Cell Physiol Biochem; 2017; 44(4):1537-1544. PubMed ID: 29197872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
